Cost Effectiveness of Infant Vaccination for Rotavirus in Canada

Doug Coyle; Kathryn Coyle; Julie A Bettinger; Scott A Halperin; Wendy Vaudry; David W Scheifele; Nicole Le Saux

doi:10.1155/2012/327054

Canadian Journal of Infectious Diseases and Medical Microbiology (Jan 2012)

Cost Effectiveness of Infant Vaccination for Rotavirus in Canada

Doug Coyle,
Kathryn Coyle,
Julie A Bettinger,
Scott A Halperin,
Wendy Vaudry,
David W Scheifele,
Nicole Le Saux

Affiliations

Doug Coyle: Department of Epidemiology and Community Medicine, University of Ottawa, Canada
Kathryn Coyle: Applied Health Economics Research Unit, Ottawa, Ontario, Canada
Julie A Bettinger: Vaccine Evaluation Center, BC Children’s Hospital, Vancouver, British Columbia, Canada
Scott A Halperin: Canadian Center for Vaccinology, IWK Health Centre, Dalhousie University, Halifax, Nova Scotia, Canada
Wendy Vaudry: Stollery Children’s Hospital, Edmonton, Alberta, Canada
David W Scheifele: Vaccine Evaluation Center, BC Children’s Hospital, Vancouver, British Columbia, Canada
Nicole Le Saux: Children’s Hospital of Eastern Ontario, University of Ottawa, Ottawa, Ontario, Canada

DOI: https://doi.org/10.1155/2012/327054
Journal volume & issue: Vol. 23, no. 2
pp. 71 – 77

Abstract

Read online

INTRODUCTION: Rotavirus is the main cause of gastroenteritis in Canadian children younger than five years of age, resulting in significant morbidity and cost. The present study provides evidence on the cost effectiveness of two alternative rotavirus vaccinations (RotaTeq [Merck Frosst Canada Ltd, Canada] and Rotarix [GlaxoSmithKline, Canada]) available in Canada.

Published in Canadian Journal of Infectious Diseases and Medical Microbiology

ISSN: 1712-9532 (Print); 1918-1493 (Online)
Publisher: Hindawi Limited
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Infectious and parasitic diseases; Science: Microbiology
Website: https://onlinelibrary.wiley.com/journal/9575

About the journal